34 MONTHS' FOLLOW-UP OF A PATIENT WITH MUCOPOLYSACCHARIDOSIS I TREATED WITH ENZYME REPLACEMENT THERAPY (LARONIDASE)

被引：0
|
作者：
Dupont, C. [1 ]
Hachem, C. E. [1 ]
Harchaoui, S. [1 ]
Ribault, V. [1 ]
Amiour, M. [1 ]
Guillot, M. [1 ]
Guffon-Fouilhoux, N. [2 ]
Maire, I. [3 ]
Froissart, R. [3 ]
机构：
[1] Hop Lisieux, Serv Pediat, Lisieux, France
[2] Hop Edouard Herriot, Serv Pediat, Lyon, France
[3] Groupement Hosp Est 59, Serv Malad Hereditaires Metab & Depistage Neonata, Ctr Biol & Pathol Est, Bron, France
来源：
CLINICAL THERAPEUTICS | 2008年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [1] A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years
    Sifuentes, Monica
    Doroshow, Robin
    Hoft, Richard
    Mason, Greg
    Walot, Irwin
    Diament, Michael
    Okazaki, Susan
    Huff, Kenneth
    Cox, Gerald F.
    Swiedler, Stuart J.
    Kakkis, Emil D.
    MOLECULAR GENETICS AND METABOLISM, 2007, 90 (02) : 171 - 180
  • [2] Laronidase (Aldurazyme®):: enzyme replacement therapy for mucopolysaccharidosis type I
    Pastores, Gregory M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (07) : 1003 - 1009
  • [3] Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I
    Jameson, Elisabeth
    Jones, Simon
    Wraith, James E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (11):
  • [4] Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I
    Jameson, Elisabeth
    Jones, Simon
    Remmington, Tracey
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [5] Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I
    Jameson, Elisabeth
    Jones, Simon
    Wraith, James E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (09):
  • [6] Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I
    Jameson, E.
    Jones, S.
    Remmington, T.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (06):
  • [7] Mucopolysaccharidosis type II in a female patient: clinical presentation and follow-up examination after 6 months of enzyme replacement therapy
    Rampazzo, A.
    Cananzi, M.
    Salviati, L.
    Tomanin, R.
    Gasparotto, N.
    Drigo, P.
    Scarpa, M.
    ACTA PAEDIATRICA, 2008, 97 : 99 - 99
  • [8] Aldurazyme® (laronidase) enzyme replacement therapy for mucopolysaccharidosis I:: A dose optimization study
    Cox, G. E.
    Giugliani, R.
    Martins, A. M.
    Valadares, E. R.
    Clarke, J. T. R.
    Goes, J. E. C.
    Worden, M. A.
    Sidman, M.
    Kakkis, E. D.
    CLINICAL THERAPEUTICS, 2007, 29 : S125 - S126
  • [9] Mucopolysaccharidosis type I: the youngest patient to be treated with enzyme replacement therapy
    Mercanti, F.
    Tomassetti, S.
    Caponi, L.
    Di Tondo, E.
    D'Ascenzo, R.
    Santoro, L.
    Petroni, V.
    Ficcadenti, A.
    ACTA PAEDIATRICA, 2008, 97 : 104 - 105
  • [10] Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up
    Tylki-Szymanska, A.
    Jurecka, A.
    Zuber, Z.
    Rozdzynska, A.
    Marucha, J.
    Czartoryska, B.
    ACTA PAEDIATRICA, 2012, 101 (01) : E42 - E47
12345